Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance

Go back to Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance
(NASDAQ: AUPH) Delayed: 17.53 --0 (-0%)
Previous Close $17.53    52 Week High $5.69 
Open $17.53    52 Week Low $1.42 
Day High $17.53    P/E N/A 
Day Low $17.53    EPS $0.00 
Volume 1,876